IFNG and cancer: Based on the findings that AG cells orchestrate their immune escape by coordinately inhibiting macrophage and T cell activities, the SEE‐EVs engineered with IFN‐γ mRNA and PD‐L1 siRNA exhibit enhanced therapeutic performance in metastasis prevention and cancer treatment.